首页> 外国专利> ANTIBODY-COUPLED T CELL RECEPTORS (ACTRs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF

ANTIBODY-COUPLED T CELL RECEPTORS (ACTRs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF

机译:抗体偶联的T细胞受体(ACTs)与trans协同刺激分子的结合及其治疗用途

摘要

Disclosed herein are genetically engineered hematopoietic cells (e.g., genetically engineered hematopoietic stem cells, or genetically engineered immune cells), which co¬ express one or more co- stimulatory polypeptides with an antibody-coupled T cell receptor (ACTR), and uses thereof for enhancing antibody-dependent cell cytotoxicity (ADCC) in a subject in need of the treatment.
机译:本文公开了基因工程造血细胞(例如,基因工程造血干细胞,或基因工程免疫细胞),其与抗体偶联的T细胞受体(ACTR)共同表达一种或多种共刺激性多肽,并将其用于在需要治疗的受试者中增强抗体依赖性细胞的细胞毒性(ADCC)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号